These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1611436)

  • 41. Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study.
    Quintero E; Carrillo M; Leoz ML; Cubiella J; Gargallo C; Lanas A; Bujanda L; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Morillas JD; Balaguer F; Muriel A;
    PLoS Med; 2016 May; 13(5):e1002008. PubMed ID: 27138769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The status of colon cancer screening].
    Fujiyoshi T
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2223-31. PubMed ID: 1929442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular screening: why haven't we started yet?
    Villa E
    Am J Gastroenterol; 1997 Dec; 92(12):2144-6. PubMed ID: 9399742
    [No Abstract]   [Full Text] [Related]  

  • 44. Screening for colorectal cancer in a high risk population.
    Gholson CF
    Gastroenterology; 1987 Oct; 93(4):916. PubMed ID: 3623032
    [No Abstract]   [Full Text] [Related]  

  • 45. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
    Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
    Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Endoscopic screening in subjects at risk for colorectal cancer].
    Lafon J
    Ann Gastroenterol Hepatol (Paris); 1995; 31(2):75-7. PubMed ID: 7618846
    [No Abstract]   [Full Text] [Related]  

  • 47. Screening of colorectal tumours using an improved faecal occult blood test. Quantitative aspects.
    Häkkinen I; Paasivuo R; Partanen P
    Gut; 1988 Sep; 29(9):1194-7. PubMed ID: 3197992
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of the efficacy of screening tests in colorectal cancer by faecal occult blood test--own experience.
    Kozłowski T; Godlewski D; Biczysko M; Grochowalski M; Nelke M; Paszkowski J; Borejsza-Wysocki M; Krokowicz L; Krokowicz P; Banasiewicz T; Drews M
    Pol Przegl Chir; 2011 Aug; 83(8):411-23. PubMed ID: 22166714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Colorectal cancer mortality can be reduced. Fecal blood screening is an efficient test].
    Kewenter J
    Lakartidningen; 1998 Jun; 95(25):2950-2. PubMed ID: 9674365
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Does prolonging the test period improve screening for colorectal cancer?].
    Hammes PH; Gnauck R
    Z Gastroenterol; 1987 Sep; 25(9):607-11. PubMed ID: 3673146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Mass screening for colorectal cancer by occult blood testing under restricted diet].
    Fujita M; Taguchi T; Nakano Y; Oota J; Kimoto Y; Kumanishi Y; Oomichi M; Usugane M; Ueda N; Tsukahara Y
    Gan No Rinsho; 1984 Jul; 30(8):925-32. PubMed ID: 6471396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical practice guidelines. Review of the recommendations for colorectal screening.
    Anderson J
    Geriatrics; 2000 Feb; 55(2):67-73; quiz 74. PubMed ID: 10711308
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patient compliance with colorectal cancer screening in general practice.
    Mant D; Fuller A; Northover J; Astrop P; Chivers A; Crockett A; Clements S; Lawrence M
    Br J Gen Pract; 1992 Jan; 42(354):18-20. PubMed ID: 1586526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening for large bowel cancer.
    Barnes R
    Practitioner; 1989 May; 233(1468):691-4. PubMed ID: 2513566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Familial polyposis.
    DeCosse JJ; Adams MB; Condon RE
    Cancer; 1977 Jan; 39(1):267-73. PubMed ID: 832240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening for colorectal cancer.
    Gazelle GS; McMahon PM; Scholz FJ
    Radiology; 2000 May; 215(2):327-35. PubMed ID: 10796903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
    Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E
    Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Self-administered faecal occult blood tests do not increase compliance with screening for colorectal cancer: results of a randomized controlled trial.
    Verne J; Kettner J; Mant D; Farmer A; Mortenson N; Northover J
    Eur J Cancer Prev; 1993 Jul; 2(4):301-5. PubMed ID: 8358281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective screening for colorectal tumors in the Tel-Aviv area: relevance of epidemiology and family history.
    Rozen P; Fireman Z; Terdiman R; Hellerstein SM; Rattan J; Gilat T
    Cancer; 1981 Feb; 47(4):827-31. PubMed ID: 7226033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The role of epidemiologic research of the natural history of cancer for evaluating cancer screening programs--a prospective study of colorectal polyps on the occurrence of colorectal cancer].
    Murakami R; Oshima A; Tsukuma H; Imanishi K; Otani T; Ishikawa H; Sato M; Fujimoto I
    Gan No Rinsho; 1989 Jan; 35(2):188-94. PubMed ID: 2704127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.